Desloratadine analysis: as a pharmaceutical preparation and after accelerating ageing

1. Caglar S., Oztunc A.: A sensitive spectrophotometric determination of desloratadine in tablets. J. AOAC Int., 90(2), 372, 2007.10.1093/jaoac/90.2.372Search in Google Scholar

2. Caglar S., Toker S.E.: Simultaneous determination of desloratadine and pseudoephedrine sulphate in tablets by high performance liquid chromatography and derivative spectrophotometry. Rev. Anal. Chem. 30, 145, 2011.Search in Google Scholar

3. El-Enany N.M., El-Sherbiny D., Belal F.: Spectrophotometric, spectrofluorometric and HPLC determination of desloratadine in dosage form and human plasma. Chem. Pharm. Bull., 15(12), 1662, 2007.10.1248/cpb.55.1662Search in Google Scholar

4. Hasnain M.S. et al.: Development and validation of an improved LC-MS/MS method for the quantification of desloratadine and its metabolite in human plasma using deuterated desloratadine as internal standard. J. Pharm. BioAllied Sci. 5(1), 74, 2013.10.4103/0975-7406.106571Search in Google Scholar

5. http://www.tlcpharmachem.com/tlc_item.php?upc=L-1027&li=le_21&sub=LSearch in Google Scholar

6. ICH harmonized tripartite guideline: validation of analytical procedures: text and methodology, Q2 (R1), Geneva, 2005, http://www.ich.org Accessed 30 August 2013.Search in Google Scholar

7. Mohamed G.G., Abou Attia F.M., Ibrahim N.S.: Development and validation of spectrophotometric and HPLC methods for the determination of desloratadine in tablets and syrup. J. Pharm. Res. 5(5), 2799, 2012.Search in Google Scholar

8. Polish Farmacopeia IX, Polish Pharmaceutical Society, Warsaw, 2011.Search in Google Scholar

9. Ponnuru V.S, Challa B.R., Nadendla R.: Quantification of desloratadine in human plasma by LC-ESI-MS/MS and application to a pharmacokinetic study. J. Pharm. Anal. 2(3), 180, 2012.10.1016/j.jpha.2012.01.008Search in Google Scholar

10. Rele R.V., Gurav P.J.: A Simple extractive spectrophotometric determination of loratadine, desloratadine and rupatadine from pharmaceutical formulations. Int. J. Pharma Bio Sci. 3(2), 89, 2012.Search in Google Scholar

11. Renger B., Vegh Z., Ferenczi-Fodor K.: Validation of thin layer and high performance thin layer chromatographic methods. J. Chromatogr. A, 1218, 2712, 2011.Search in Google Scholar

12. Srinubabu G. et al.: Development and validation of high-throughput liquid chromatography-tandem mass spectrometric method for simultaneous quantification of loratadine and desloratadine in human plasma. J. Chromatogr. B, 860(2), 202, 2007.10.1016/j.jchromb.2007.10.036Search in Google Scholar

13. Vlase L. et al.: Determination of loratadine and its active metabolite in human plasma by high- performance liquid chromatography with mass spectrometry detection. J. Pharm. Biomed. Anal. 44(3), 652, 2007.10.1016/j.jpba.2006.08.013Search in Google Scholar

14. Yang L.Y., Rudewicz P.J.: Application of new liquid chromatography - tandem mass spectrometry technologies for drug development support. J. Chromatogr. A, 926(1), 43, 2001. 10.1016/S0021-9673(01)00963-3Search in Google Scholar